Brought to you by 
Bayer licenses PCR patent access from Roche
13 Jul 1999
Executive Summary
Bayer licensed nonexclusive, worldwide access to Roche's PCR patents. Rights include manufacturing and marketing PCR-based diagnostic products in the areas of infectious disease, genetics, oncology, tissue typing, and therapeutic drug monitoring.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Therapeutic Drug Monitoring
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Bayer licenses PCR patent access from Roche
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice